SEC Form D · filed October 25, 2018
AsclepiX Therapeutics, Inc
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (15)
Jordan J. Green · Baltimore, MDDirectorJoshua S. Barer · Baltimore, MDDirectorAleksander S. Popel, Phd · Baltimore, MDDirectorKevin S. Slawin, Md · Baltimore, MDDirectorWendy Perrow · Baltimore, MDExec · DirectorGreg Couch · Lexington, KYExec · DirectorWilliam M. Daniher · Walnut Creek, CADirectorHironobu C. Tamba · Walnut Creek, CADirectorRichard C. Jelinek · Walnut Creek, CADirectorAnkur L. Jain · New York, NYDirectorRyan Gill · Calgary, Alberta, CanadaExec · DirectorChris Kneeland · Calgary, Alberta, CanadaDirectorBrenton K. Ahrens · Dublin, IrelandDirectorMark K. Chin · Dublin, IrelandDirectorPatrick J. Heron · Dublin, IrelandDirector Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗